Quality of life in children with tuberous sclerosis complex: A pediatric cohort study
- PMID: 33225634
- PMCID: PMC7871787
- DOI: 10.1111/cns.13473
Quality of life in children with tuberous sclerosis complex: A pediatric cohort study
Abstract
Aims: To evaluate the quality-of-life (QOL) impairment and identify the possible risk factors in patients with tuberous sclerosis complex (TSC) in China.
Methods: The parent proxy-report PedsQL 4.0 Generic Core Scales were administered to 124 caregivers of children with TSC (aged 2-18 years). For comparison, the survey was also conducted in a demographically group-matched sample of healthy controls (HCs) (aged 2-18 years).
Results: A total of 124 children with TSC and 206 HCs were recruited. The mean parent proxy-report total scale score, physical health summary score, and psychosocial health summary score for children with TSC were 65.0 (SD 19.7), 77.6 (SD 22.9), and 58.0 (SD 21.3), respectively, compared with the HC values of 83.6 (SD 14.3), 87.2 (SD 16.9), and 82.8 (SD 15.9). There were statistically significant differences between the two groups (P < .0001). TSC2 mutation (P = .033), epilepsy (P = .011), seizure before 2 years old (P = .001), course of epilepsy (more than 2 years) (P = .001), high reported seizure frequency (more than once a month) (HRSF) (P = .007), multiple antiepileptic drugs (≥2) (P = .002), intellectual disability (ID) (mild and moderate ID, P < .0001, and severe and profound ID, P < .0001), and TANDs (P < .0001) (ADHD, P = .004; agoraphobia, P = .007; and social anxiety disorder, P < .0001) were closely related to lower QOL scores.
Conclusion: This study is the first large cohort study on QOL in children with TSC in China. The results of the PedsQL 4.0 indicated that the QOL of children with TSC is significantly lower than that of HCs. TSC2 mutation, epilepsy, early onset, long disease course and HRSF, ID, and TANDs are risk factors for poor QOL.
Keywords: PedsQL; TSC; child; epilepsy; generic core scale; health.
© 2020 The Authors. CNS Neuroscience & Therapeutics Published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Quality of life of children with tuberous sclerosis complex.Arch Dis Child. 2019 Oct;104(10):972-978. doi: 10.1136/archdischild-2018-316394. Epub 2019 May 23. Arch Dis Child. 2019. PMID: 31122923
-
A quantitative cross-sectional study of the burden of caring for patients with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex-associated epilepsy in Japan.Epilepsy Behav. 2024 May;154:109741. doi: 10.1016/j.yebeh.2024.109741. Epub 2024 Mar 30. Epilepsy Behav. 2024. PMID: 38555725
-
Quality of life in patients with Tuberous Sclerosis Complex (TSC).Eur J Paediatr Neurol. 2019 Nov;23(6):801-807. doi: 10.1016/j.ejpn.2019.09.006. Epub 2019 Sep 13. Eur J Paediatr Neurol. 2019. PMID: 31543331
-
[Neuropsychiatric manifestations in Tuberous Sclerosis Complex (TSC): diagnostic guidelines, TAND concept and therapy with mTOR inhibitors].Z Kinder Jugendpsychiatr Psychother. 2019 Mar;47(2):139-153. doi: 10.1024/1422-4917/a000604. Epub 2018 Aug 6. Z Kinder Jugendpsychiatr Psychother. 2019. PMID: 30080117 Review. German.
-
Resective surgery in tuberous Sclerosis complex, from Penfield to 2018: A critical review.Rev Neurol (Paris). 2019 Mar;175(3):163-182. doi: 10.1016/j.neurol.2018.11.002. Epub 2019 Jan 25. Rev Neurol (Paris). 2019. PMID: 30686486 Review.
Cited by
-
Novel insights into the interaction between long non-coding RNAs and microRNAs in glioma.Mol Cell Biochem. 2021 Jun;476(6):2317-2335. doi: 10.1007/s11010-021-04080-x. Epub 2021 Feb 13. Mol Cell Biochem. 2021. PMID: 33582947 Review.
-
Long-term distress throughout one's life: health-related quality of life, economic and caregiver burden of patients with neurofibromatosis type 1 in China.Front Public Health. 2024 Aug 21;12:1398803. doi: 10.3389/fpubh.2024.1398803. eCollection 2024. Front Public Health. 2024. PMID: 39234078 Free PMC article.
-
Impact of Vitamin D and IL-1β on Quality of Life in Pediatric Drug-Resistant Epilepsy.J Multidiscip Healthc. 2024 Nov 25;17:5571-5581. doi: 10.2147/JMDH.S493116. eCollection 2024. J Multidiscip Healthc. 2024. PMID: 39619161 Free PMC article.
-
Disease Burden and Associated Factors in Chinese Patients with Tuberous Sclerosis Complex: Results of a Patient and Caregiver Survey.Int J Gen Med. 2025 Mar 17;18:1481-1495. doi: 10.2147/IJGM.S507375. eCollection 2025. Int J Gen Med. 2025. PMID: 40123818 Free PMC article.
-
Assessment of tuberous sclerosis-associated neuropsychiatric disorders using the MINI-KID tool: a pediatric case-control study.Orphanet J Rare Dis. 2021 Apr 17;16(1):181. doi: 10.1186/s13023-021-01814-4. Orphanet J Rare Dis. 2021. PMID: 33865427 Free PMC article.
References
-
- Cotter JA. An update on the central nervous system manifestations of tuberous sclerosis complex. Acta Neuropathol. 2019;139:613‐624. - PubMed
-
- Lu DS, Karas PJ, Krueger DA, Weiner HL. Central nervous system manifestations of tuberous sclerosis complex. Am J Med Genet C Semin Med Genet. 2018;178:291‐298. - PubMed
-
- Peron A, Northrup H. Tuberous sclerosis complex. Am J Med Genet C Semin Med Genet. 2018;178:274‐277. - PubMed
-
- Curatolo P, Moavero R, de Vries PJ. Neurological and neuropsychiatric aspects of tuberous sclerosis complex. Lancet Neurol. 2015;14:733‐745. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical